202 related articles for article (PubMed ID: 19782116)
1. Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells.
Nobre HV; Cunha GM; de Vasconcelos LM; Magalhães HI; Oliveira Neto RN; Maia FD; de Moraes MO; Leal LK; Viana GS
Neurochem Int; 2010 Jan; 56(1):51-8. PubMed ID: 19782116
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
3. CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.
Aguiar LM; Macêdo DS; Vasconcelos SM; Oliveira AA; de Sousa FC; Viana GS
Brain Res; 2008 Jan; 1191():192-9. PubMed ID: 18164694
[TBL] [Abstract][Full Text] [Related]
4. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.
Xu L; Sheng J; Tang Z; Wu X; Yu Y; Guo H; Shen Y; Zhou C; Paraoan L; Zhou J
Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression.
Fernandez-Gomez FJ; Pastor MD; Garcia-Martinez EM; Melero-Fernandez de Mera R; Gou-Fabregas M; Gomez-Lazaro M; Calvo S; Soler RM; Galindo MF; Jordán J
Neurobiol Dis; 2006 Nov; 24(2):296-307. PubMed ID: 16978869
[TBL] [Abstract][Full Text] [Related]
8. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro.
Mu X; He G; Cheng Y; Li X; Xu B; Du G
Pharmacol Biochem Behav; 2009 Jun; 92(4):642-8. PubMed ID: 19327378
[TBL] [Abstract][Full Text] [Related]
9. Amburoside A, a glucoside from Amburanacearensis, protects mesencephalic cells against 6-hydroxydopamine-induced neurotoxicity.
Leal LK; Nobre Júnior HV; Cunha GM; Moraes MO; Pessoa C; Oliveira RA; Silveira ER; Canuto KM; Viana GS
Neurosci Lett; 2005 Nov; 388(2):86-90. PubMed ID: 16039060
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
Shi XR; Hong ZY; Liu HR; Zhang YC; Zhu YZ
Neurochem Int; 2011 Jul; 58(8):851-60. PubMed ID: 21093517
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats.
Song L; Kong M; Ma Y; Ba M; Liu Z
Brain Res; 2009 Jun; 1276():171-9. PubMed ID: 19393228
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats.
Bové J; Marin C; Bonastre M; Tolosa E
Synapse; 2002 Dec; 46(4):251-7. PubMed ID: 12373740
[TBL] [Abstract][Full Text] [Related]
13. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats.
Aguiar LM; Nobre HV; Macêdo DS; Oliveira AA; Freitas RM; Vasconcelos SM; Cunha GM; Sousa FC; Viana GS
Pharmacol Biochem Behav; 2006 Jul; 84(3):415-9. PubMed ID: 16844208
[TBL] [Abstract][Full Text] [Related]
15. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation.
Chen HQ; Jin ZY; Li GH
Neurosci Lett; 2007 May; 417(2):112-7. PubMed ID: 17399896
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
Ochi M; Shiozaki S; Kase H
Neuroscience; 2004; 127(1):223-31. PubMed ID: 15219684
[TBL] [Abstract][Full Text] [Related]
17. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
[TBL] [Abstract][Full Text] [Related]
18. Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E.
Ueda S; Sakakibara S; Nakadate K; Noda T; Shinoda M; Joyce JN
Neurosci Lett; 2005 Jun; 380(3):252-6. PubMed ID: 15862896
[TBL] [Abstract][Full Text] [Related]
19. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.
Roghani M; Niknam A; Jalali-Nadoushan MR; Kiasalari Z; Khalili M; Baluchnejadmojarad T
Brain Res Bull; 2010 Jul; 82(5-6):279-83. PubMed ID: 20558255
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
